Your session is about to expire
← Back to Search
Imaging
Electromagnetic Acoustic Imaging for Liver Cancer
N/A
Waitlist Available
Led By Chirag Patel, MD
Research Sponsored by Enhanced Medical
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 18 months
Awards & highlights
Summary
A single-centre, industry sponsored, proof-of-concept pilot study to assess the feasibility of Electromagnetic Acoustic Imaging (EMA) as an imaging platform in the visualization of hepatic tumours.
Eligible Conditions
- Liver Cancer
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 18 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~18 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
EMA (colour scale) images will be compared to baseline US grey-scale images for a specific target lesion, as determined by standard of care imaging (US, CT, MRI or PET) and/or histologically proven lesion in a given subject.
Secondary study objectives
US grey-scale and EMA colour maps will be obtained from both target liver lesions and background liver tissue from the same subject and compared.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Electromagnetic Acoustic ImagingExperimental Treatment1 Intervention
Find a Location
Who is running the clinical trial?
Enhanced MedicalLead Sponsor
Sunnybrook Health Sciences CentreOTHER
671 Previous Clinical Trials
1,564,605 Total Patients Enrolled
1 Trials studying Liver Cancer
8,000 Patients Enrolled for Liver Cancer
Chirag Patel, MDPrincipal InvestigatorSunnybrook Health Sciences Centre
Share this study with friends
Copy Link
Messenger